These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11121442)

  • 1. Endocytosis and recycling of the HIV coreceptor CCR5.
    Signoret N; Pelchen-Matthews A; Mack M; Proudfoot AE; Marsh M
    J Cell Biol; 2000 Dec; 151(6):1281-94. PubMed ID: 11121442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
    Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
    J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
    Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
    J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
    Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
    J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.
    Mosier DE; Picchio GR; Gulizia RJ; Sabbe R; Poignard P; Picard L; Offord RE; Thompson DA; Wilken J
    J Virol; 1999 May; 73(5):3544-50. PubMed ID: 10196243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells.
    Longden J; Cooke EL; Hill SJ
    Br J Pharmacol; 2008 Apr; 153(7):1513-27. PubMed ID: 18223665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of CC chemokine receptors by AOP-RANTES.
    Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
    J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways.
    Blanpain C; Wittamer V; Vanderwinden JM; Boom A; Renneboog B; Lee B; Le Poul E; El Asmar L; Govaerts C; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 2001 Jun; 276(26):23795-804. PubMed ID: 11323418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.
    Escola JM; Kuenzi G; Gaertner H; Foti M; Hartley O
    J Biol Chem; 2010 Dec; 285(53):41772-80. PubMed ID: 21041313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.
    Sabbe R; Picchio GR; Pastore C; Chaloin O; Hartley O; Offord R; Mosier DE
    J Virol; 2001 Jan; 75(2):661-71. PubMed ID: 11134280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional antagonist Met-RANTES: a modified agonist that induces differential CCR5 trafficking.
    Kiss DL; Longden J; Fechner GA; Avery VM
    Cell Mol Biol Lett; 2009; 14(4):537-47. PubMed ID: 19448977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex.
    Vila-Coro AJ; Mellado M; Martín de Ana A; Martínez-A C; Rodríguez-Frade JM
    J Immunol; 1999 Sep; 163(6):3037-44. PubMed ID: 10477567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation.
    Rusconi S; La Seta-Catamancio S; Kurtagic S; Galazzi M; Arienti D; Trabattoni D; Wilken J; Thompson DA; Offord RE; Galli M; Clerici M
    AIDS Res Hum Retroviruses; 1999 Jul; 15(10):861-7. PubMed ID: 10408722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine-induced phosphorylation of CC chemokine receptor 5 (CCR5).
    Olbrich H; Proudfoot AE; Oppermann M
    J Leukoc Biol; 1999 Mar; 65(3):281-5. PubMed ID: 10080528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
    Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
    J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
    Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
    Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
    J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.